SPIDER TOXINS AFFECTING GLUTAMATE RECEPTORS - POLYAMINES IN THERAPEUTIC NEUROCHEMISTRY

被引:88
|
作者
USHERWOOD, PNR [1 ]
BLAGBROUGH, IS [1 ]
机构
[1] UNIV BATH, SCH PHARM & PHARMACOL, BATH BA2 7AY, AVON, ENGLAND
关键词
D O I
10.1016/0163-7258(91)90012-B
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Polyamine amide toxins obtained from venoms of spiders and wasps interact selectively with ionotropic glutamate receptors (GLU-R) of vertebrate central nervous systems. The sites and modes of action of these polyamide amide toxins are reviewed with particular reference to their structure-activity relationships. Qualitatively, their effects on GLU-R are identical to those exerted by polyamines such as spermine, but the polyamine amides are more potent. These compounds (a) potentiate and (b) antagonize GLU-R, the latter arising through open channel block. For the N-methyl-D-aspartate receptor this non-competitive antagonism probably arises through binding of toxin to the Mg2+ site(s) located in the channel gated by this receptor. Similarities and differences between GLU-R in vertebrates and in invertebrates with respect to their interactions with polyamines and polyamine amide toxins are discussed. In both groups the low specificity of these compounds is illustrated by their antagonism at nicotinic acetylcholine receptors in addition to GLU-R. Electrophysiological studies, including those employing Xenopus oocytes, are reviewed and future prospects for the use of polyamine amides in therapy are discussed.
引用
收藏
页码:245 / 268
页数:24
相关论文
共 50 条
  • [41] Therapeutic potential of group III metabotropic glutamate receptors
    Lavreysen, Hilde
    Dautzenberg, Frank M.
    CURRENT MEDICINAL CHEMISTRY, 2008, 15 (07) : 671 - 684
  • [42] GABA AND GLUTAMATE RECEPTORS AS THERAPEUTIC TARGETS IN NEURODEGENERATIVE DISORDERS
    KROGSGAARDLARSEN, P
    PHARMACOLOGY & TOXICOLOGY, 1992, 70 (02): : 95 - 104
  • [44] Metabotropic Glutamate Receptors as Therapeutic Targets for Cognitive Disorders
    Gravius, A.
    Pietraszek, M.
    Dekundy, A.
    Danysz, W.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2010, 10 (02) : 187 - 206
  • [45] Metabotropic Glutamate Receptors: A Review on Prospectives and Therapeutic Aspects
    Vaidya, Ankur
    Jain, Shweta
    Jain, Abhishek K.
    Agrawal, Abhinav
    Kashaw, Sushil K.
    Jain, Sanjay K.
    Agrawal, Ram K.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2013, 13 (13) : 1967 - 1981
  • [46] Glutamate Receptors as Therapeutic Targets for Parkinson's Disease
    Johnson, Kari A.
    Conn, P. Jeffrey
    Niswender, Colleen M.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2009, 8 (06) : 475 - 491
  • [47] Metabotropic glutamate receptors as therapeutic targets in epilepsy.
    Meldrum, BS
    BRITISH JOURNAL OF PHARMACOLOGY, 2000, 131
  • [48] Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder
    Jaso, Brittany A.
    Niciu, Mark J.
    Iadarola, Nicolas D.
    Lally, Niall
    Richards, Erica M.
    Park, Minkyung
    Ballard, Elizabeth D.
    Nugent, Allison C.
    Machado-Vieira, Rodrigo
    Zarate, Carlos A., Jr.
    CURRENT NEUROPHARMACOLOGY, 2017, 15 (01) : 57 - 70
  • [49] Amino acid substitutions in the pore of rat glutamate receptors at sites influencing block by polyamines
    Panchenko, VA
    Glasser, CR
    Partin, KM
    Mayer, ML
    JOURNAL OF PHYSIOLOGY-LONDON, 1999, 520 (02): : 337 - 357
  • [50] Creation of novel spider toxin analogs to adoptas probes for visualization of glutamate receptors
    Tateaki, Wakamiya
    Takahiro, Nishimaru
    Kiyoe, Mori
    Yoshihiro, Yamaguchi
    JOURNAL OF PEPTIDE SCIENCE, 2008, 14 (08) : 96 - 96